Lumito
在场
Lumito 是一家在股票代码 LUMITO (SE) 下上市的公司。
高管
查看带有其 9 名主要高管的组织结构图
Lumito 搜索最多的简介
- Sanna Wallenborg, Chief Executive Officer
- Stefan Andersson-Engels, Board Member
- Kerstin Jakobsson, Chairman of the Board
创建提醒
跟踪 Lumito 的高管变动
生物技术
Lumito 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Lumito 的最新新闻稿
- Warrants of series TO6 were subscribed to approximately 94 percent and Lumito receives approximately SEK 12.6 million | Lumito
- The last day of trading with the warrants of series TO6 in Lumito AB is today, November 12, 2024 | Lumito
- Members of Lumitos board and management team intend to exercise warrants of series TO6 | Lumito
- Lumito AB publishes Quarterly Report 3, 2024 | Lumito
- The subscription price for exercise of warrants of series TO6 in Lumito AB is set to SEK 0.39 and the subscription period commences today November 4, 2024 | Lumito
- Lumito signs Letter of Intent with Scientific Advisor | Lumito
- Lumito AB signs a Letter of Intent with Katana Labs GmbH | Lumito
- Lumito AB publishes Quarterly Report 2, 2024 | Lumito
- Lumito has CE-marked its first product SCIZYS | Lumito
- The subscription price for exercise of warrants of series TO5 in Lumito AB is set to SEK 0.75 and the subscription period commences today May 27 | Lumito
- View more press releases Close
通过电子邮件
